Viruses and autoimmunity

Autoimmunity

Volumn 38, Issue 8, 2005, Pages 559-565

  Kim, Bumseok ^a   Deshpande Kaistha, Shilpa ^b   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b CSJM UNIVERSITY   (India)

Author keywords

Autoimmune diseases; Bystander activation; Molecular mimicry; Self tolerance

Indexed keywords

CD4 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G; MYELIN PROTEIN; VIRUS PROTEIN;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BYSTANDER EFFECT; CELL CLONING; DISEASE EXACERBATION; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MOLECULAR MECHANICS; NONHUMAN; REVIEW; T LYMPHOCYTE; TRANSGENICS; VIRUS INHIBITION; VIRUS INTERFERENCE; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; MOLECULAR MIMICRY; VIRUSES;

EID: 30844431722     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930500356583     Document Type: Review

References (63)

1. von Herrath, MG and Fujinami, RS and Whitton, JL. 2003; Microorganisms and autoimmunity: Making the barren field fertile? Nat Rev Microbiol, 1, pp. 151-157.
2. Benoist, C and Mathis, D. 2001; Autoimmunity provoked by infection: How good is the case for T-cell epitope mimicry? Nat Immunol, 2, pp. 797-801.
3. Rouse, BT and Deshpande, S. 2002; Viruses and autoimmunity: An affair but not a marriage contract. Rev Med Virol, 12, pp. 107-113.
4. Oldstone, MB. 1998; Molecular mimicry and immune-mediated diseases. FASEB J, 12, pp. 1255-1265.
5. Whitton, JL and Fujinami, RS. 1999; Viruses as triggers of autoimmunity: Facts and fantasies. Curr Opin Microbiol, 2, pp. 392-397.
6. Christen, U and von Herrath, MG. 2005; Infections and autoimmunity-good or bad? J Immunol, 174, pp. 7481-7486.
7. Christen, U and von Herrath, MG. 2004; Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol, 40, pp. 1113-1120.
8. Olson, JK and Croxford, JL and Miller, SD. 2004; Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Mol Immunol, 40, pp. 1103-1108.
9. Panoutsakopoulou, V and Cantor, H. 2001; On the relationship between viral infection and autoimmunity. J Autoimmun, 16, pp. 341-345.
10. Oldstone, MB and Nerenberg, M and Southern, P and Price, J and Lewicki, H. 1991; Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell, 65, pp. 319-331.
11. Ohashi, PS and Oehen, S and Buerki, K and Pircher, H and Ohashi, CT and Odermatt, B and Malissen, B and Zinkernagel, RM and Hengartner, H. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell, 65, pp. 305-317.
12. von Herrath, MG and Dockter, J and Oldstone, MB. 1994; How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity, 1, pp. 231-242.
13. Selin, LK and Nahill, SR and Welsh, RM. 1994; Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med, 179, pp. 1933-1943.
14. Olson, JK and Croxford, JL and Calenoff, MA and Dal Canto, MC and Miller, SD. 2001; A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest, 108, pp. 311-318.
15. Lehmann, PV and Sercarz, EE and Forsthuber, T and Dayan, CM and Gammon, G. 1993; Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today, 14, pp. 203-208.
16. Miller, SD and Vanderlugt, CL and Begolka, WS and Pao, W and Yauch, RL and Neville, KL and Katz-Levy, Y and Carrizosa, A and Kim, BS. 1997; Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med, 3, pp. 1133-1136.
17. Croxford, JL and Olson, JK and Miller, SD. 2002; Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev, 1, pp. 251-260.
18. Olson, JK and Girvin, AM and Miller, SD. 2001; Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J Virol, 75, pp. 9780-9789.
19. Avery, AC and Zhao, ZS and Rodriguez, A and Bikoff, EK and Soheilian, M and Foster, CS and Cantor, H. 1995; Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature, 376, pp. 431-434.
20. Zhao, ZS and Granucci, F and Yeh, L and Schaffer, PA and Cantor, H. 1998; Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection. Science, 279, pp. 1344-1347.
21. Panoutsakopoulou, V and Sanchirico, ME and Huster, KM and Jansson, M and Granucci, F and Shim, DJ and Wucherpfennig, KW and Cantor, H. 2001; Analysis of the relationship between viral infection and autoimmune disease. Immunity, 15, pp. 137-147.
22. Deshpande, SP and Lee, S and Zheng, M and Song, B and Knipe, D and Kapp, JA and Rouse, BT. 2001; Herpes simplex virus-induced keratitis: Evaluation of the role of molecular mimicry in lesion pathogenesis. J Virol, 75, pp. 3077-3088.
23. Verjans, GM and Remeijer, L and Mooy, CM and Osterhaus, AD. 2000; Herpes simplex virus-specific T-cells infiltrate the cornea of patients with herpetic stromal keratitis: No evidence for autoreactive T-cells. Invest Ophthalmol Vis Sci, 41, pp. 2607-2612.
24. Olson, JK and Croxford, JL and Miller, SD. 2001; Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol, 14, pp. 227-250.
25. Toubi, E and Shoenfeld, Y. 2004; Toll-like receptors and their role in the development of autoimmune diseases. Autoimmunity, 37, pp. 183-188.
26. Horwitz, MS and Bradley, LM and Harbertson, J and Krahl, T and Lee, J and Sarvetnick, N. 1998; Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat Med, 4, pp. 781-785.
27. Huster, KM and Panoutsakopoulou, V and Prince, K and Sanchirico, ME and Cantor, H. 2002; T-cell-dependent and -independent pathways to tissue destruction following herpes simplex virus-1 infection. Eur J Immunol, 32, pp. 1414-1419.
28. Rouse, BT and Suvas, S. 2004; Regulatory cells and infectious agents: Detentes cordiale and contraire. J Immunol, 173, pp. 2211-2215.
29. Belkaid, Y and Rouse, BT. 2005; Natural regulatory T-cells in infectious disease. Nat Immunol, 6, pp. 353-360.
30. Suvas, S and Kumaraguru, U and Pack, CD and Lee, S and Rouse, BT. 2003; CD4+CD25+T-cells regulate virus-specific primary and memory CD8+T-cell responses. J Exp Med, 198, pp. 889-901.
31. Suvas, S and Azkur, AK and Kim, BS and Kumaraguru, U and Rouse, BT. 2004; CD4+CD25+regulatory T-cells control the severity of viral immunoinflammatory lesions. J Immunol, 172, pp. 4123-4132.
32. Gangappa, S and Deshpande, SP and Rouse, BT. 1999; Bystander activation of CD4(+) T-cells can represent an exclusive means of immunopathology in a virus infection. Eur J Immunol, 29, pp. 3674-3682.
33. Gangappa, S and Deshpande, SP and Rouse, BT. 2000; Bystander activation of CD4+T-cells accounts for herpetic ocular lesions. Invest Ophthalmol Vis Sci, 41, pp. 453-459.
34. Horwitz, MS and Sarvetnick, N. 1999; Viruses, host responses, and autoimmunity. Immunol Rev, 169, pp. 241-253.
35. Banerjee, K and Deshpande, S and Zheng, M and Kumaraguru, U and Schoenberger, SP and Rouse, BT. 2002; Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol, 219, pp. 108-118.
36. Gangappa, S and Babu, JS and Thomas, J and Daheshia, M and Rouse, BT. 1998; Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J Immunol, 161, pp. 4289-4300.
37. Deshpande, S and Zheng, M and Lee, S and Banerjee, K and Gangappa, S and Kumaraguru, U and Rouse, BT. 2001; Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol, 167, pp. 2902-2910.
38. Kurt-Jones, EA and Chan, M and Zhou, S and Wang, J and Reed, G and Bronson, R and Arnold, MM and Knipe, DM and Finberg, RW. 2004; Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA, 101, pp. 1315-1320.
39. Zheng, M and Deshpande, S and Lee, S and Ferrara, N and Rouse, BT. 2001; Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol, 75, pp. 9828-9835.
40. Zheng, M and Schwarz, MA and Lee, S and Kumaraguru, U and Rouse, BT. 2001; Control of stromal keratitis by inhibition of neovascularization. Am J Pathol, 159, pp. 1021-1029.
41. Talbot, PJ and Paquette, JS and Ciurli, C and Antel, JP and Ouellet, F. 1996; Myelin basic protein and human coronavirus 229E cross-reactive T-cells in multiple sclerosis. Ann Neurol, 39, pp. 233-240.
42. Soldan, SS and Berti, R and Salem, N and Secchiero, P and Flamand, L and Calabresi, PA and Brennan, MB and Maloni, HW and McFarland, HF and Lin, HC and Patnaik, M and Jacobson, S. 1997; Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med, 3, pp. 1394-1397.
43. Steinman, L and Oldstone, MB. 1997; More mayhem from molecular mimics. Nat Med, 3, pp. 1321-1322.
44. Banki, K and Colombo, E and Sia, F and Halladay, D and Mattson, DH and Tatum, AH and Massa, PT and Phillips, PE and Perl, A. 1994; Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med, 180, pp. 1649-1663.
45. ter Meulen, V and Liebert, UG. 1993; Measles virus-induced autoimmune reactions against brain antigen. Intervirology, 35, pp. 86-94.
46. Munch, M and Hvas, J and Christensen, T and Moller-Larsen, A and Haahr, S. 1997; The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand Suppl, 169, pp. 59-64.
47. Stohlman, SA and Hinton, DR. 2001; Viral induced demyelination. Brain Pathol, 11, pp. 92-106.
48. Goswami, KK and Lange, LS and Mitchell, DN and Cameron, KR and Russell, WC. 1984; Does simian virus 5 infect humans? J Gen Virol, 65(Pt8), pp. 1295-1303.
49. Croxford, JL and Olson, JK and Anger, HA and Miller, SD. 2005; Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: Implications for the pathogenesis of multiple sclerosis. J Virol, 79, pp. 8581-8590.
50. Atkinson, MA and Bowman, MA and Campbell, L and Darrow, BL and Kaufman, DL and Maclaren, NK. 1994; Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest, 94, pp. 2125-2129.
51. Maclaren, NK and Alkinson, MA. 1997; Insulin-dependent diabetes mellitus: The hypothesis of molecular mimicry between isleT-cell antigens and microorganisms. Mol Med Today, 3, pp. 76-83.
52. Karges, WJ and Ilonen, J and Robinson, BH and Dosch, HM. 1995; Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms. Mol Aspects Med, 16, pp. 79-213.
53. Aydin, Y and Ustun, I and Erol, K and Ozkaya, E and Gul, K and Berker, D and Unal, M and Delibasi, T and Altundag, K and Guler, S. 2005; Herpes simplex type-2 encephalitis masked by diabetic ketoacidosis. J Natl Med Assoc, 97, pp. 722-724.
54. Takeda, N. 2003; Cardiomyopathy: Molecular and immunological aspects (review). Int J Mol Med, 11, pp. 13-16.
55. Schwimmbeck, PL and Dyrberg, T and Drachman, DB and Oldstone, MB. 1989; Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest, 84, pp. 1174-1180.
56. Eddy, S and Wim, R and Peter, VE and Tanja, R and Jan, T and Werner, VS. 1999; Myasthenia gravis: Another autoimmune disease associated with hepatitis C virus infection Dig Dis Sci, 44, pp. 186-189.
57. James, JA and Neas, BR and Moser, KL and Hall, T and Bruner, GR and Sestak, AL and Harley, JB. 2001; Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum, 44, pp. 1122-1126.
58. Sekigawa, I and Nawata, M and Seta, N and Yamada, M and Iida, N and Hashimoto, H. 2002; Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol, 20, pp. 559-564.
59. Romero Portales, M and De Diego Lorenzo, A and Rivera, J and Garcia Monforte, A and Piqueras Alcol, B and Garcia Duran, F and Cos Arregui, E and Clemente Ricote, G. 1997; Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection. Rev Esp Enferm Dig, 89, pp. 591-598.
60. McMurray, RW and Elbourne, K. 1997; Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum, 26, pp. 689-701.
61. Csepregi, A and Nemesanszky, E and Rojkovich, B and Poor, G. 2001; Rheumatoid arthritis and hepatitis B virus: Evaluating the pathogenic link. J Rheumatol, 28, pp. 474-477.
62. Balandraud, N and Roudier, J and Roudier, C. 2004; Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev, 3, pp. 362-367.
63. Muller-Ladner, U and Gay, RE and Gay, S. 1998; Retroviral sequences in rheumatoid arthritis synovium. Int Rev Immunol, 17, pp. 273-290.